While POMC deficiency is very rare, 1–5% of severely obese individuals harbor heterozygous mutations in MC4R. We sought to assess the efficacy of Setmelanotide in human MC4R deficiency. The gene discussed is POMC; the disease is hyperinsulinemic hypoglycemia, familial, 4.